Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Return on Sales (2016 - 2025)

Skinvisible (SKVI) has disclosed Return on Sales for 16 consecutive years, with 51.67% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 2181.0% to 51.67% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 53.43% through Dec 2025, up 952.0% year-over-year, with the annual reading at 53.43% for FY2025, 952.0% up from the prior year.
  • Return on Sales hit 51.67% in Q4 2025 for Skinvisible, down from 50.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.52% in Q2 2021 to a low of 302.4% in Q1 2023.
  • Historically, Return on Sales has averaged 55.59% across 5 years, with a median of 55.93% in 2025.
  • Biggest five-year swings in Return on Sales: plummeted -29625bps in 2023 and later skyrocketed 24449bps in 2024.
  • Year by year, Return on Sales stood at 1.83% in 2021, then plummeted by -4379bps to 81.78% in 2022, then rose by 26bps to 60.86% in 2023, then fell by -21bps to 73.48% in 2024, then increased by 30bps to 51.67% in 2025.
  • Business Quant data shows Return on Sales for SKVI at 51.67% in Q4 2025, 50.05% in Q3 2025, and 55.79% in Q2 2025.